Related Experiment Video
Updated: May 21, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus
L Watson1, K Tullus, S D Marks
1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Alder Hey Children's NHS Foundation Trust Hospital, Eaton Road, Liverpool, L12 2AP, UK. louise.watson@liverpool.ac.uk
Insights
Children with juvenile-onset systemic lupus erythematosus (JSLE) show higher serum concentrations of sphingosine-1-phosphate (S1P). This finding suggests S1P may play a role in JSLE
Area of Science:
- Immunology
- Rheumatology
- Biochemistry
Background:
- Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator implicated in inflammation and autoimmune diseases.
- Elevated S1P levels are associated with various inflammatory conditions, but its role in pediatric autoimmune diseases remains under-explored.
Purpose of the Study:
- To investigate serum and urinary concentrations of S1P in children diagnosed with juvenile-onset systemic lupus erythematosus (JSLE).
- To compare S1P levels in JSLE patients with those in healthy controls and disease controls (Henoch Schonlein Purpura).
Main Methods:
- A cross-sectional study involving JSLE patients from the UK JSLE Cohort Study.
- Prospective collection of serum and urine samples, alongside clinical and demographic data.
- Comparison of S1P levels against Henoch Schonlein Purpura (HSP) and healthy controls (HC).
Main Results:
- Serum S1P concentrations were significantly elevated in JSLE patients compared to both HSP patients and healthy controls (p < 0.016 and p < 0.003, respectively).
- A trend towards higher serum S1P was observed in JSLE patients with active lupus nephritis, though not statistically significant (p=0.355).
- No significant difference in urine S1P concentrations was found between JSLE patients and healthy controls (p=0.889).
Conclusions:
- This study provides the first evidence of increased serum S1P levels in a cohort of pediatric patients with JSLE.
- The findings suggest a potential role for S1P in the underlying mechanisms of JSLE.
- Further research is warranted to elucidate the specific contribution of S1P to JSLE pathophysiology.
Purpose:
Sphingosine-1-phosphate (S1P) is an active sphingolipid with chemotactic abilities and has been linked to inflammatory mediators and autoimmune disease. The aim of this study was to assess whether children with juvenile-onset systemic lupus erythematosus (JSLE) express increased systemic and/or urinary concentrations of S1P.
Methods:
A subgroup of patients participating in the UK JSLE Cohort Study, were invited to participate. Cross sectional serum and urine samples were prospectively collected along with demographic and standard clinical data. Results were compared to a cohort of disease controls (Henoch Schonlein Purpura; HSP) and healthy controls (HC).
Results:
The median age of JSLE patients (n = 15) was 13.6 years (7.2-16.9 years). The serum concentrations of S1P in JSLE patients (7.4 uM, IQR 6.3-12.3 uM) were statistically significantly increased when compared to patients with HSP (n = 10; 5.2 uM, IQR 4.0-7.9 uM; p = 0.016) and HCs (n = 10; 3.8 uM, IQR 2.1-5.8 uM; p = 0.003). There was a trend towards increased serum S1P concentrations between patients with active lupus nephritis (n = 8; 8.7 uM, IQR 6.2-15.3 uM) compared to lupus non-nephritis (n = 7; 6.6 uM, IQR 6.3-10.6 uM; p = 0.355). No relationship was found between disease activity markers and S1P. Urine S1P concentrations were no different between JSLE patients (56.0 nM, IQR 40.3-96.6 nM) and HCs (58.7 nM, IQR 0-241.9 nM; p = 0.889).
Conclusions:
We have demonstrated, for the first time, an increased serum concentration of S1P in a cohort of JSLE patients. These findings highlight a role of S1P in the pathophysiology of JSLE that warrants further investigation.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
